The Tony Blair Institute for Global Change: Why We Must Develop Digital-Health Tools With Women in Mind

The Women’s Brain Project, in collaboration with the Tony Blair Institute for Global Change, and the Stanford Health Innovation Lab contributed to an explainer article entitled, Why We Must Develop Digital-Health Tools With Women in Mind.

We are extremely proud to have contributed to this piece of research with the Tony Blair Institute for Global Change, where we brought examples of sex differences in digital health tools. At the Women’s Brain Project this is an active area of research that we carry out together with partners such as Altoida.

–Dr Antonella Santuccione Chadha, Chief Executive Officer of the Women’s Brain Project

Read here how precision medicine has the potential to offer individualized healthcare to everyone– so long as its tools are developed conscientiously.

“We are extremely proud to have contributed to this piece of research with the Tony Blair Institute, where we brought examples of sex differences in digital health tools. At the Women's Brain Project this is an active area of research that we carry out together with partners such as Altoida.”-Dr Antonella Santuccione Chief Executive Officer of the Women’s Brain Project

Leave a Reply

Your email address will not be published. Required fields are marked *

Return Home

Make a Donation

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.